Press What’s news at AbelsonTaylor Group
Select category
What pharma marketers should know about Bluesky
In the ever-changing world of social media, Bluesky has emerged as an intriguing new platform, particularly for HCPs and the broader pharma industry. As a decentralized, ad-free network, it offers a unique environment compared to other mainstream social platforms. In a featured article in MedAdNews, Helen Hoye, associate director of engagement strategy at AbelsonTaylor Group, shares some key things for pharma marketer to know about Bluesky.
Read more: https://www.pharmalive.com/what-pharma-marketers-should-know-about-bluesky/
Media Contact:
Recent Posts
Amy Restko Promoted to Vice President, Engagement Strategy at AbelsonTaylor Group
AbelsonTaylor Group today announced the promotion of Amy Restko to Vice President, Engagement Strategy. A strategic leader with expertise in...
Read Press Read more Amy Restko Promoted to Vice President, Engagement Strategy at AbelsonTaylor GroupCybersecurity considerations in pharma marketing: Trust must come first
“Responsible AI adoption is essential to protecting our clients, our agency, and the patients ultimately served by the work we...
In the News Read more Cybersecurity considerations in pharma marketing: Trust must come firstThe Leadership Circle: Kelly Ofman and the New Era of Pharma Communication
AbelsonTaylor Group’s current VP & Account Director analyzes the challenges of launching category-defining therapies, managing brands under global scrutiny, and...
In the News Read more The Leadership Circle: Kelly Ofman and the New Era of Pharma CommunicationConnect with us
Find out what's top of mind for the people reimagining health and wellness advertising.